HTRA1 (HtrA serine peptidase 1)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
5654 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
HtrA serine peptidase 1 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
HTRA1 |
SynonymsGene synonyms aliases
|
ARMD7, CADASIL2, CARASIL, HtrA, L56, ORF480, PRSS11 |
ChromosomeChromosome number
|
10 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
10q26.13 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs113993969 |
G>A |
Pathogenic |
Missense variant, coding sequence variant |
rs113993970 |
C>T |
Pathogenic, likely-pathogenic |
Stop gained, coding sequence variant |
rs113993971 |
C>T |
Pathogenic, likely-pathogenic |
Stop gained, coding sequence variant |
rs149294320 |
C>A,T |
Uncertain-significance, conflicting-interpretations-of-pathogenicity, likely-benign |
Coding sequence variant, synonymous variant |
rs373287445 |
C>A,G,T |
Conflicting-interpretations-of-pathogenicity |
Coding sequence variant, synonymous variant |
rs587776445 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs587776447 |
T>C |
Pathogenic |
Coding sequence variant, missense variant |
rs587776449 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs587776873 |
G>A,C |
Pathogenic |
Coding sequence variant, missense variant |
rs864622782 |
C>A |
Pathogenic |
Coding sequence variant, missense variant |
rs864622783 |
G>A |
Pathogenic |
Splice acceptor variant |
rs1267457680 |
A>C,G |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1554952277 |
G>C |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1554952291 |
C>T |
Pathogenic |
Stop gained, coding sequence variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q92743 |
Protein name |
Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11) |
Protein function |
Serine protease with a variety of targets, including extracellular matrix proteins such as fibronectin. HTRA1-generated fibronectin fragments further induce synovial cells to up-regulate MMP1 and MMP3 production. May also degrade proteoglycans, such as aggrecan, decorin and fibromodulin. Through cleavage of proteoglycans, may release soluble FGF-glycosaminoglycan complexes that promote the range and intensity of FGF signals in the extracellular space. Regulates the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. Inhibits signaling mediated by TGF-beta family members. This activity requires the integrity of the catalytic site, although it is unclear whether TGF-beta proteins are themselves degraded. By acting on TGF-beta signaling, may regulate many physiological processes, including retinal angiogenesis and neuronal survival and maturation during development. Intracellularly, degrades TSC2, leading to the activation of TSC2 downstream targets. |
PDB |
2JOA
,
2YTW
,
3NUM
,
3NWU
,
3NZI
,
3TJN
,
3TJO
,
3TJQ
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00219 |
IGFBP |
37 → 89 |
Insulin-like growth factor binding protein |
Domain |
PF07648 |
Kazal_2 |
108 → 155 |
Kazal-type serine protease inhibitor domain |
Domain |
PF13365 |
Trypsin_2 |
204 → 342 |
|
Domain |
PF17820 |
PDZ_6 |
413 → 464 |
PDZ domain |
Domain |
|
Sequence |
|
Sequence length |
480 |
Interactions |
View interactions |
PathwaysPathway information has different metabolic/signaling pathways associated with genes. Each record is hyperlinked to a complete information page which also includes links to the KEGG/Reactome pathway database.
|
|
Associated diseases
|
Causal |
Disease name |
Disease term |
dbSNP ID |
References |
Age-related macular degeneration |
Macular Degeneration, Age-Related, 7, Age related macular degeneration, NON RARE IN EUROPE: Age-related macular degeneration |
rs2133900556, rs199474657, rs2274700, rs1410996, rs61750120, rs1800728, rs62654397, rs61749423, rs61751412, rs61749439, rs61751398, rs61752417, rs62645946, rs1801269, rs62646860, rs61750142, rs61750145, rs61750152, rs61751377, rs61753029, rs61751407, rs61751389, rs61750645, rs61750648, rs879255520, rs752147871, rs886044750, rs886044749, rs746541266, rs756840095, rs886044725, rs749526785, rs1057518955, rs1057518767, rs371489809, rs1064793014, rs1571264574, rs1659524475 |
17053108, 20385819, 23326517, 23577725, 28703135, 29346644 |
Coronary artery disease |
Coronary Artery Disease |
rs137852988, rs121918313, rs-1, rs121918529, rs121918531, rs137852340, rs405509, rs1555800701, rs1215189537 |
29212778 |
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy |
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2, Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy |
rs113993970, rs864622781, rs781563777, rs864622782, rs864622783, rs1554948318, rs1554950655, rs1273355332, rs1554952277, rs1554952291, rs1267457680 |
24500651, 26063658, 24357685 |
Vascular leukoencephalopathy |
Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy |
rs28937321, rs28933696, rs28933697, rs864621964, rs864621965, rs28933698, rs137852641, rs137852642, rs864621966, rs267606915, rs797045014, rs863225297, rs1438626607, rs1285584068, rs1555727942, rs1188569102, rs1323608032, rs1555729451, rs1555729486, rs1174625611, rs775836288, rs1555729604, rs1555730176, rs1555730188, rs1555730189, rs201118034, rs1555729346, rs1568361608, rs200881673, rs1555730197, rs145069047, rs-1, rs1599382214, rs1202763005, rs764148985, rs769773673, rs762734007, rs1599391536, rs1599394806, rs760768552 |
22900900, 21482952, 25772074, 11889251, 24357685, 19387015, 21115960, 24535794, 24500651, 26063658, 25770224, 27164673, 25957642 |
Neurofibrosarcoma |
Neurofibrosarcoma |
rs137852604 |
27723760 |
Lung cancer |
Malignant neoplasm of lung |
rs121913530, rs121913529, rs878855122, rs1057519784, rs770315135 |
27935865 |
Moyamoya disease |
Moyamoya Disease |
rs121434527, rs121434528, rs387906592, rs397514563, rs797045187, rs1555675538, rs1568149971, rs1599150380, rs-1, rs2079443410 |
|
Leukoencephalopathy |
Leukoencephalopathy |
rs34757931 |
|
|
Unknown |
Disease name |
Disease term |
dbSNP ID |
References |
Alopecia |
Alopecia |
|
26063658 |
Cadasil syndrome |
CADASIL Syndrome |
|
|
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy and migraine |
CADASILM |
|
|
Cerebral microangiopathy |
Cerebral Small Vessel Diseases |
|
26063658 |
Cerebral small vessel disease |
HTRA1-related autosomal dominant cerebral small vessel disease |
|
|
Dementia |
Dementia |
|
24500651 |
Dysarthria |
Dysarthria |
|
|
Exudative macular degeneration |
Exudative age-related macular degeneration, exudative macular degeneration |
|
28775256, 28703135 |
Impaired cognition |
Impaired cognition |
|
26063658 |
Intervertebral disc degeneration |
Intervertebral Disc Degeneration |
|
26063658 |
Lung neoplasms |
Lung Neoplasms |
|
27935865 |
Malignant peripheral nerve sheath tumor |
Malignant Peripheral Nerve Sheath Tumor, Malignant peripheral nerve sheath tumor |
|
27723760 |
Status cribrosum |
Status cribrosum |
|
|
Stroke |
Cerebrovascular accident |
|
29531354 |
Subcortical infarcts |
Recurrent subcortical infarcts |
|
|
Transient ischemic attack |
Transient Ischemic Attack |
|
|
|
|
|